Oms approva l’uso d’emergenza del vaccino Johnson&Johnson
The first boxes of the Johnson and Johnson COVID vaccines at the McKesson Facility in Shepherdsville, Kentucky, USA, 01 March 2021. US Food and Drug Administration (FDA) on 27 February approved Johnson & Johnson single dose coronavirus vaccine, of which 3.9 doses will be distributed all over US. ANSA/TIMOTHY D. EASLEY / POOL
Commenta per primo